Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products

The Journal of Clinical Pharmacology

Volumn 35, Issue 9 S, 1995, Pages 18S-24S

  O'Connell, Mary Beth ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTRONE; ESTRONE SULFATE; ETHINYLESTRADIOL; GESTAGEN; PIPERAZINE ESTRONE SULFATE; UNCLASSIFIED DRUG;

ANDROGEN METABOLISM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MIXTURE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; ESTRONE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PHARMACODYNAMICS; REVIEW; TISSUE DISTRIBUTION; TRANSDERMAL DRUG ADMINISTRATION;

ABSORPTION; ANDROGENS; ANIMAL; ESTROGENS; HUMAN; PROGESTATIONAL HORMONES; PROTEIN BINDING; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0029098973     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1995.tb04143.x     Document Type: Article

References (45)

1. The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States)
2. 17B‐estradiol for postmenopausal estrogen replacement therapy
3. Pharmacokinetics of estrogen
4. Monitoring of hormone replacement therapy (letter)
5. Sustained‐release subdermal estradiol implants: a new alternative in estrogen replacement therapy
6. Reliability and interrelations among serum sex hormones in postmenopausal women
7. Inhibition of oral contraceptive steroid‐metabolizing enzymes by steroids and drugs
8. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17‐estradiol
9. Interactions with oral contraceptives
10. Effect of natural estrogen on the serum level of follicle‐stimulating hormone, estradiol, and estrone in post‐menopausal women and its effect on endometrium
11. Influence of esterified estrogens and medroxyprogesterone on lipid metabolism and sex steroids: a study in oophorectomized women
12. A prospective one‐year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids
13. Biologic effects of transdermal estradiol
14. The menopause: health implications and clinical management
15. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women
16. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17‐estradiol: comparison with conventional oral estrogens used for hormone replacement
17. Absorption of estrogens from vaginal creams
18. Plasma levels of oestrone, oestradiol and gonadotropins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin)
19. Systemic absorption and sustained effects of vaginal estrogen creams
20. A randomized comparison of nonoral estradiol delivery in postmenopausal women
21. Selecting constant serum estradiol levels achieved by vaginal rings
22. Pharmacokinetics of 17‐dihydroequilin sulfate and 17‐dihydroequilin in normal postmenopausal women
23. Pharmacokinetics of equilin and equilin sulfate in normal postmenopausal women and men
24. Transport of equine estrogens: binding of conjugated and unconjugated equine estrogens with human serum proteins
25. Metabolic clearance rate of equilin sulfate and its conversion to plasma equilin, conjugated and unconjugated equilenin, 17‐dihydroequilin, and 17‐dihydroequilenin in normal postmenopausal women and men under steady state conditions
26. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy
27. Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy
28. Cigarette smoking, serum estrogens, and bone loss during hormone‐replacement therapy early after menopause
29. Antipyrine pharmacokinetics in women receiving conjugated estrogens
30. Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women
31. Antipyrine elimination in saliva after low‐dose combined or progestogen‐only oral contraceptive steroids
32. Impairment of antipyrine metabolism by low‐dose oral contraceptive steroids
33. Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens
34. Pharmacokinetics of oxaprozin in women receiving conjugated estrogen
35. Interaction between estrogen and dilantin in a menopausal woman
36. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database
37. Effect of oral contraceptives on trizolam, temazepam, alprazolam, and lorazepam kinetics
38. Effects of oral contraceptive steroids on acetaminophen metabolism and elimination
39. Alterations in prednisolone disposition as a result of oral contraceptive use and dose
40. Impaired elimination of caffeine by oral contraceptive steroids
41. Serum estrone concentrations and coronary artery disease in postmenopausal women
42. Endogenous estrogen levels and calcium intakes in postmenopausal women: relationships with cortical bone measures
43. Minimal levels of serum estradiol prevent postmenopausal bone loss
44. Antioxidant potential of specific estrogens on lipid peroxidation
45. Biologic effects of equilin sulfate in postmenopausal women